SPEN Pathways
Pathway 1: First Seizure
Pathway 2: Diagnosis and Initial Management of Epilepsy
Pathway 3: Continuing Epileptic Seizures
Publication Date: July 2024
Revision Date: March 2025
These pathways are not intended to be construed or to serve as a standard of care. Standards of care are determined on the basis of all clinical data available for an individual case and are subject to change as scientific knowledge and technology advance and patterns of care evolve. Adherence to pathway recommendations will not ensure a successful outcome in every case, nor should they be construed as including all proper methods of care or excluding other acceptable methods of care aimed at the same results. The ultimate judgement must be made by the appropriate healthcare professional(s) responsible for clinical decisions regarding a particular clinical procedure or treatment plan. This judgement should only be arrived at following discussion of the options with the patient, covering the diagnostic and treatment choices available. It is advised, however, that significant departures from the national pathways or any local guidance derived from them should be fully documented in the patient’s case notes at the time the relevant decision is taken.
SIGN 159 National Clinical Guideline
SIGN 159 National Clinical Guideline
SPEN Joint Clinic Guidance
SPEN Joint Paediatric Epilepsy Clinic Guidance
SPEN Buccal Midazolam Guideline
SPEN Buccal Midazolam Guideline